Dr Hubertus Erlen is a member of the European Advisory Board.
In addition to his board membership at Bridgepoint he is Vice-Chairman of the Supervisory Board of Bayer Schering Pharma AG, where he worked for over 30 years, culminating in his appointment as Chief Executive Officer from 2001 until 2006. He is also is a member of the Supervisory Boards of Celesio AG and the Central Advisory Board of Commerzbank AG.
